<DOC>
	<DOCNO>NCT00642811</DOCNO>
	<brief_summary>The purpose study see Ticagrelor , new oral reversible anti-platelet medication , affect platelet . Anti-platelet agent medication block formation blood clot prevent clump platelet . Blood clots prevent u bleed , form inside artery formation link risk medical problem heart attack stroke . This study investigate effect Ticagrelor inhibition platelet aggregation compare clopidogrel patient previously identify non-responsive clopidogrel .</brief_summary>
	<brief_title>A Study Antiplatelet Effects Comparing Ticagrelor ( Ticag . - AZD6140 ) With Clopidogrel ( Clop . ) Responder Non-responders</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Patients document stable Coronary Artery Disease ( CAD ) ( stable angina , previous MI history , previous history revascularization ) Females child bear potential must negative pregnancy test prior receive study drug willing use hormonal contraceptive addition double barrier contraception History Acute Coronary Syndromes within 12 month screen need revascularization ( angioplasty coronary artery bypass graft ( CABG ) ) Any acute chronic unstable condition past 30 day Have increase bleeding risk , eg , recent gastrointestinal bleed , uncontrolled high blood pressure , low platelet count , recent major trauma History intolerance allergy aspirin clopidogrel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>coronary artery disease ( CAD )</keyword>
	<keyword>heart attack</keyword>
	<keyword>stable angina</keyword>
</DOC>